Prudential Financial’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Prudential Financial’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-225,376	Closed	-$3.03M	–	2752
2023 Q1	$3.03M	Buy	+225,376	New	+$3.9M	﹤0.01%	1086
2020 Q1	–	Sell	-8,459	Closed	-$1.05M	–	2469
2019 Q4	$1.05M	Buy	+8,459	New	+$757K	﹤0.01%	1837
2019 Q3	–	Sell	-2,660	Closed	-$212K	–	2493
2019 Q2	$212K	Buy	2,660 +328	+14%	+$29.4K	﹤0.01%	2323
2019 Q1	$261K	Buy	2,332 +42	+2%	+$4.59K	﹤0.01%	2247
2018 Q4	$231K	Sell	2,290 -30	-1%	-$3.11K	﹤0.01%	2205
2018 Q3	$293K	Buy	+2,320	New	+$246K	﹤0.01%	2206
2015 Q3	–	Sell	-910	Closed	-$220K	–	2266
2015 Q2	$220K	Buy	910 +20	+2%	+$5.33K	﹤0.01%	2124
2015 Q1	$251K	Buy	+890	New	+$193K	﹤0.01%	2103
2014 Q4	–	Sell	-1,090	Closed	-$258K	–	2238
2014 Q3	$258K	Sell	1,090 -840	-44%	-$214K	﹤0.01%	2069
2014 Q2	$457K	Buy	1,930 +620	+47%	+$163K	﹤0.01%	2040
2014 Q1	$432K	Buy	+1,310	New	+$442K	﹤0.01%	1989

Other funds holding ICPT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

DCM

DG Capital Management New York $326M AUM 39.67% 1-Year Est. Return

Prudential Financial's ICPT Position: Q2 2023 in Review

Prudential Financial sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q2 2023, closing a stake of 225,376 shares — an estimated $3.03M sold.

Prudential Financial first reported a position in ICPT in Q1 2014 and held it in 11 quarters. The position peaked at $3.03M in Q1 2023. 126 funds tracked by Wall St. Rank hold ICPT as of Q2 2023.

Prudential Financial reported no remaining Intercept Pharmaceuticals, Inc. position as of Q2 2023 after selling out during the quarter.
Prudential Financial sold 225,376 Intercept Pharmaceuticals, Inc. shares in Q2 2023, an estimated $3.03M.
Prudential Financial first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2014 and held it in 11 quarters.
Prudential Financial's Intercept Pharmaceuticals, Inc. position peaked at $3.03M in Q1 2023.
126 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q2 2023.

Based on Prudential Financial's 13F filing for Q2 2023, filed 11 Aug 2023.